Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ALB | P02768 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4'-Thiothymidine SCHEMBL6266871 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL1942500 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL13083838 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL23897578 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL6311407 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL23897630 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL3517588 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL9520953 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL12642446 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL30381070 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021202788-A2 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| US-20120225837-A1 | MEDICINAL AGENT FOR DISEASE ASSOCIATED WITH EPSTEIN-BARR VIRUS, AND METHOD FOR SCREENING OF THE MEDICINAL AGENT | KYOTO UNIVERSITY (JP) | 2012-09-06 | — | — | US | disclosed |
| EP-2189161-B1 | MEDICINAL AGENT FOR DISEASE ASSOCIATED WITH EPSTEIN-BARR VIRUS, AND METHOD FOR SCREENING OF THE MEDICINAL AGENT | YAMASA CORP (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20100330563-A1 | MEDICINAL AGENT FOR DISEASE ASSOCIATED WITH EPSTEIN-BARR VIRUS, AND METHOD FOR SCREENING OF THE MEDICINAL AGENT | YAMASA CORPORATION (JP) | 2010-12-30 | — | — | US | disclosed |
| EP-2189161-A1 | MEDICINAL AGENT FOR DISEASE ASSOCIATED WITH EPSTEIN-BARR VIRUS, AND METHOD FOR SCREENING OF THE MEDICINAL AGENT | YAMASA CORPORATION (JP) | 2010-05-26 | — | — | EP | disclosed |